Header Logo

Connection

Liisa Selin to Male

This is a "connection" page, showing publications Liisa Selin has written about Male.
Connection Strength

0.447
  1. Kenney LL, Carter EP, Gil A, Selin LK. T cells in the brain enhance neonatal mortality during peripheral LCMV infection. PLoS Pathog. 2021 01; 17(1):e1009066.
    View in: PubMed
    Score: 0.041
  2. Gil A, Kamga L, Chirravuri-Venkata R, Aslan N, Clark F, Ghersi D, Luzuriaga K, Selin LK. Epstein-Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor a and ? Repertoires. mBio. 2020 03 17; 11(2).
    View in: PubMed
    Score: 0.039
  3. Aslan N, Watkin LB, Gil A, Mishra R, Clark FG, Welsh RM, Ghersi D, Luzuriaga K, Selin LK. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires. mBio. 2017 Dec 05; 8(6).
    View in: PubMed
    Score: 0.033
  4. Watkin LB, Mishra R, Gil A, Aslan N, Ghersi D, Luzuriaga K, Selin LK. Unique influenza A?cross-reactive memory CD8 T-cell receptor repertoire has a potential to protect against EBV seroconversion. J Allergy Clin Immunol. 2017 10; 140(4):1206-1210.
    View in: PubMed
    Score: 0.032
  5. Kenney LL, Cornberg M, Chen AT, Emonet S, de la Torre JC, Selin LK. Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis. J Virol. 2015 Nov; 89(21):10786-801.
    View in: PubMed
    Score: 0.028
  6. Kraft AR, Wlodarczyk MF, Kenney LL, Selin LK. PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection. J Virol. 2013 Dec; 87(23):12636-47.
    View in: PubMed
    Score: 0.025
  7. Wlodarczyk MF, Kraft AR, Chen HD, Kenney LL, Selin LK. Anti-IFN-? and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cells. J Immunol. 2013 Mar 15; 190(6):2736-46.
    View in: PubMed
    Score: 0.024
  8. Chen AT, Cornberg M, Gras S, Guillonneau C, Rossjohn J, Trees A, Emonet S, de la Torre JC, Welsh RM, Selin LK. Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope. PLoS Pathog. 2012; 8(4):e1002633.
    View in: PubMed
    Score: 0.022
  9. Nie S, Lin SJ, Kim SK, Welsh RM, Selin LK. Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire. Am J Pathol. 2010 May; 176(5):2107-12.
    View in: PubMed
    Score: 0.019
  10. Cornberg M, Clute SC, Watkin LB, Saccoccio FM, Kim SK, Naumov YN, Brehm MA, Aslan N, Welsh RM, Selin LK. CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections. J Immunol. 2010 Mar 15; 184(6):2825-38.
    View in: PubMed
    Score: 0.019
  11. Nie S, Cornberg M, Selin LK. Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity. J Immunol. 2009 Nov 15; 183(10):6554-60.
    View in: PubMed
    Score: 0.019
  12. Cornberg M, Sheridan BS, Saccoccio FM, Brehm MA, Selin LK. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry. J Virol. 2007 Jan; 81(2):934-44.
    View in: PubMed
    Score: 0.015
  13. Chen HD, Fraire AE, Joris I, Welsh RM, Selin LK. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol. 2003 Oct; 163(4):1341-55.
    View in: PubMed
    Score: 0.012
  14. Benn CS, Amenyogbe N, Bj?rkman A, Dom?nguez-Andr?s J, Fish EN, Flanagan KL, Klein SL, Kollmann TR, Kyvik KO, Netea MG, Rod NH, Schaltz-Buchholzer F, Shann F, Selin L, Thysen SM, Aaby P. Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines. Drug Saf. 2023 05; 46(5):439-448.
    View in: PubMed
    Score: 0.012
  15. Kim SK, Brehm MA, Welsh RM, Selin LK. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J Immunol. 2002 Jul 01; 169(1):90-8.
    View in: PubMed
    Score: 0.011
  16. Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, Selin LK. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol. 2002 Jul; 3(7):627-34.
    View in: PubMed
    Score: 0.011
  17. Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, Selin LK. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol. 2001 Nov; 2(11):1067-76.
    View in: PubMed
    Score: 0.011
  18. Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsuda E, Welsh RM. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol. 2001 Jun 01; 166(11):6784-94.
    View in: PubMed
    Score: 0.010
  19. Selin LK, Varga SM, Wong IC, Welsh RM. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med. 1998 Nov 02; 188(9):1705-15.
    View in: PubMed
    Score: 0.009
  20. Shin HM, Kapoor VN, Kim G, Li P, Kim HR, Suresh M, Kaech SM, Wherry EJ, Selin LK, Leonard WJ, Welsh RM, Berg LJ. Transient expression of ZBTB32 in anti-viral CD8+ T cells limits the magnitude of the effector response and the generation of memory. PLoS Pathog. 2017 Aug; 13(8):e1006544.
    View in: PubMed
    Score: 0.008
  21. Che JW, Daniels KA, Selin LK, Welsh RM. Heterologous Immunity and Persistent Murine Cytomegalovirus Infection. J Virol. 2017 Jan 15; 91(2).
    View in: PubMed
    Score: 0.008
  22. Selin LK, Vergilis K, Welsh RM, Nahill SR. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med. 1996 Jun 01; 183(6):2489-99.
    View in: PubMed
    Score: 0.007
  23. Fish EN, Flanagan KL, Furman D, Klein SL, Kollmann TR, Jeppesen DL, Levy O, Marchant A, Namachivayam S, Netea MG, Plebanski M, Rowland-Jones SL, Selin LK, Shann F, Whittle HC. Changing oral vaccine to inactivated polio vaccine might increase mortality. Lancet. 2016 Mar 12; 387(10023):1054-1055.
    View in: PubMed
    Score: 0.007
  24. Che JW, Selin LK, Welsh RM. Evaluation of non-reciprocal heterologous immunity between unrelated viruses. Virology. 2015 Aug; 482:89-97.
    View in: PubMed
    Score: 0.007
  25. Flanagan KL, Klein SL, Skakkebaek NE, Marriott I, Marchant A, Selin L, Fish EN, Prentice AM, Whittle H, Benn CS, Aaby P. Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine. 2011 Mar 16; 29(13):2349-54.
    View in: PubMed
    Score: 0.005
  26. Selin LK, Hammond GW, Aoki FY. Neonatal herpes simplex virus infection in Manitoba, 1980 to 1986, and implications for preventive strategies. Pediatr Infect Dis J. 1988 Oct; 7(10):733-4.
    View in: PubMed
    Score: 0.004
  27. Kim SK, Cornberg M, Wang XZ, Chen HD, Selin LK, Welsh RM. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J Exp Med. 2005 Feb 21; 201(4):523-33.
    View in: PubMed
    Score: 0.003
  28. Varga SM, Selin LK, Welsh RM. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss. J Immunol. 2001 Feb 01; 166(3):1554-61.
    View in: PubMed
    Score: 0.003
  29. Zarozinski CC, Fynan EF, Selin LK, Robinson HL, Welsh RM. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol. 1995 Apr 15; 154(8):4010-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.